GSK rejects three Unilever bids to buy consumer healthcare arm, says unit was “fundamentally undervalued”
Sunday, January 16, 2022 London head office of GlaxoSmithKline on July 30, 2007. Image: Ian Wilson. United Kingdom-based pharmaceutical giant GlaxoSmithKline (GSK) confirmed January 15 it had rejected three “unsolicited, conditional and non-binding proposals” by Unilever to acquire its Consumer Read more…